浙江京圣药业有限公司
Zhejiang Jingsheng Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
19
19 products shown
🇺🇸 DMF
14
14 products shown
🇪🇺 CEP
2
2 products shown
Total
35
registrations
🇨🇳 CDE 注册 (19)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Apalutamide 阿帕他胺 | 956104-40-8 | Class A | Y20240000773 |
| Apatinib 甲磺酸阿帕替尼 | 231277-92-2 | Class A | Y20210001228 |
| Aprocitentan 阿普昔腾坦 | 1103522-45-7 | Class I | Y20250001009 |
| Baclofen 巴氯芬 | 1134-47-0 | Class I | Y20250001443 |
| Benvitimod 本维莫德 | 79338-84-4 | Class A | Y20240001364 |
| Bilastine 比拉斯汀 | 202189-78-4 | Class I | Y20260000515 |
| Brexpiprazole 布瑞哌唑 | 913611-97-9 | Class A | Y20240001143 |
| Canagliflozin 卡格列净 | 842133-18-0 | Class A | Y20230000828 |
| Edoxaban Tosylate 甲苯磺酸艾多沙班 | 480449-70-5 | Class A | Y20230000820 |
| Enzalutamide 氘恩扎鲁胺 | 915087-33-1 | Class I | Y20240001146 |
| Ezetimibe 依折麦布 | 163222-33-1 | Class A | Y20230001252 |
| Finerenone HS236 | 1050477-31-0 | Class I | Y20250000767 |
| Ibrutinib 伊布替尼 | 936563-96-1 | Class I | Y20240001142 |
| Losartan Potassium 氯沙坦钾 | 114798-26-4 | Class A | Y20210000982 |
| Mirogabalin 苯磺酸美洛加巴林 | 1138245-13-2 | Class I | Y20250001280 |
| Relugolix 瑞卢戈利 | 737789-87-6 | Class I | Y20250000261 |
| Sitagliptin 西格列汀 | 486460-32-6 | Class A | Y20250000108 |
| Telmisartan 替米沙坦 | 144701-48-4 | Class I | Y20250000587 |
| Vonoprazan 富马酸伏诺拉生 | 881681-00-1 | Class A | Y20240000933 |
🇺🇸 DMF 注册 (14)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Canaglifozin 卡格列净 | 842133-18-0 | 39627 | 2024-03-26 |
| Dapagliflozin HS-10353 | 461432-26-8 | 39656 | 2024-03-14 |
| Dapagliflozin (free Base) 达格列净 | 461432-26-8 | 41471 | 2025-03-20 |
| Empagliflozin 恩格列净 | 864070-44-0 | 39603 | 2024-03-25 |
| Enzalutamide 氘恩扎鲁胺 | 915087-33-1 | 39955 | 2024-06-12 |
| Ezetimibe 依折麦布 | 163222-33-1 | 39410 | 2024-01-17 |
| Finerenone HS236 | 1050477-31-0 | 41289 | 2025-03-20 |
| Methyl N-[(2'-cyanobiphenyl-4-yl)methyl]-l-valinate Hydrochloride | - | 36496 | 2022-10-31 |
| Mirogabalin Besilate | 1138245-21-2 | 41755 | 2025-06-27 |
| N-(4-(1-cyanocyclopentyl) Phenyl)-2-((pyridin-4-ylmethyl) Amino) Nicotinamide (internal Code: Atn-5) | 811803-05-1 | 35394 | 2020-11-30 |
| Sitagliptin Hydrochloride 盐酸西格列汀 | 486459-71-6 | 39440 | 2024-01-27 |
| Sitagliptin Phosphate Monohydrate | 654671-77-9 | 39957 | 2024-06-27 |
| Telmisartan 替米沙坦 | 144701-48-4 | 41756 | 2025-06-27 |
| Vonoprazan Fumarate 富马酸伏诺拉生 | 881681-01-2 | 39476 | 2024-01-26 |
🇪🇺 CEP 注册 (2)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Sitagliptin Phosphate Monohydrate, Process II | 654671-77-9 | CEP 2023-453 - Rev 01 | 2025-08-12 |
| Sitagliptin Phosphate Monohydrate, Process III | 654671-77-9 | CEP 2025-109 - Rev 00 | 2025-07-25 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12